Yamamura Ken-ichi, Araki Kimi
Division of Developmental Genetics, Institute of Molecular Embryology and Genetics, Kumamoto University, 2-2-1 Honjo, Kumamoto 860-0811, Japan.
Cancer Sci. 2008 Jan;99(1):1-6. doi: 10.1111/j.1349-7006.2007.00611.x. Epub 2007 Sep 17.
The complete human DNA sequence of the human genome was published in 2004 and we entered the postgenomic era. However, many studies showed that gene function is much more complex than we expected, and that mutation of disease genes does not give any clue for molecular mechanisms for disease development. Since the first report on gene knockout mice in 1989, knockout mice have been shown to be a powerful tool for functional genomics and for the dissection of developmental processes in human diseases. In accordance with this successful application of knockout mice, three major mouse knockout programs are now underway worldwide, to mutate all protein-encoding genes in mouse embryonic stem cells using a combination of gene trapping and gene targeting. We developed the exchangeable gene trap method suitable for large scale mutagenesis in mice. In this method we can produce null mutation and post-insertional modification, enabling replacement of the marker gene with a gene of interest and conditional knockout. We herein discuss the effect of this gene-driven type approach for cancer research, especially for finding the genes that are related to cancer, but are paid little attention in hypothesis-driven cancer research.
人类基因组的完整DNA序列于2004年公布,我们进入了后基因组时代。然而,许多研究表明,基因功能比我们预期的要复杂得多,而且疾病基因的突变并不能为疾病发展的分子机制提供任何线索。自1989年首次报道基因敲除小鼠以来,基因敲除小鼠已被证明是功能基因组学以及剖析人类疾病发育过程的有力工具。鉴于基因敲除小鼠的这一成功应用,目前全球正在进行三个主要的小鼠基因敲除项目,旨在利用基因捕获和基因靶向相结合的方法,使小鼠胚胎干细胞中的所有蛋白质编码基因发生突变。我们开发了适用于小鼠大规模诱变的可交换基因捕获方法。在这种方法中,我们可以产生无效突变和插入后修饰,从而能够用感兴趣的基因替换标记基因并进行条件性敲除。我们在此讨论这种基因驱动型方法对癌症研究的影响,特别是对于寻找与癌症相关但在假设驱动的癌症研究中很少受到关注的基因。